Agenus reported $159.72M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US $ 159.72M 3.34M
Amgen AMGN:US $ 12618M 268M
AstraZeneca AZN:LN 1791796.84M 60282.28M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Celldex Therapeutics CLDX:US $ 29.95M 15.39M
Chemocentryx CCXI:US $ 76.08M 7.27M
CSL CSL:AU $ 10.3B 6.82B
Dynavax Technologies DVAX:US $ 345.2M 121M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Genocea Biosciences GNCA:US $ 18.03M 0.65M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 3783500M 1355700M
Glaxosmithkline GSK:US $ 37835M 13557M
Immunogen IMGN:US $ 87.07M 2.95M
Intrexon XON:US $ 29.9M 4.3M
Jiangsu Hengrui Me. 600276:CH CH 3.84B 1.09B
Karyopharm Therapeutics KPTI:US $ 62.54M 3.8M
Macrogenics MGNX:US $ 50.88M 16.22M
Merck MRK:GR € 9718M 489M
Northwest Biotherapeutics NWBO:US 98.16M 31.85M
Novartis NOVN:VX SF 27646M 2161M
Novavax NVAX:US $ 2156.24M 104.77M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Rigel Pharmaceuticals RIGL:US $ 54.96M 4.27M
Sangamo Biosciences SGMO:US $ 119.99M 1.46M
Veracyte VCYT:US $ 59.34M 3.2M
YTE INCY:US $ 926.67M 40.51M